Lung cancer is the most common malignant neoplasm both in the world and Poland. More than half of non--small-cell and small-cell cancer cases are diagnosed in the over 65 years old patients. Although large number ofthe incidence in the population of elderly persons the standards of treatment are not established. In this articlelocoregional treatment (surgery, radiotherapy) and systemic treatment (chemotherapy, target therapy) in the elderlypatients with non-small-cell and small-cell cancer are discussed.Rak płuca jest najczęstszym nowotworem złośliwym na świecie i w Polsce. Ponad połowa przypadków zarówno niedrobnokomórkowego, jak drobnokomórkowego raka płuca jest rozpoznawana u pacjentów powyżej 65 roku życia. Mimo dużej liczby zachorowań ...
BackgroundLung cancer has progressively become a disease of older people, with the median age at dia...
Background: Seventy-five percent of newly diagnosed patients with small-cell lung cancer (SCLC) are ...
Objectives: Over 20% of all newly diagnosed Dutch patients with small-cell lung cancer (SCLC) are ag...
Wstęp: Nowotwór złośliwy płuca jest drugim, co do częstości diagnozowanym w Polsce oraz główną przy...
Lung cancer is in Poland the most common malignancy. Non-small cell lung cancer (NSCLC) accounts for...
Rak płuca jest najczęściej występującym w Polsce i na świecie nowotworem złośliwym, niestety zbyt pó...
Lung cancer is the most common human malignancy. Treatment of this tumor is still unsatisfactory and...
Lung cancer is the most common cause of cancer-related death both in men and women in Poland and wor...
AbstractLung cancer is the most common cause of cancer death. With the aging of the population, more...
Malignant neoplasms are in Poland a major social problem not only in the older age groups, but they ...
There is a growing number of evidence that elderly cancer patients can benefit oncology treatment. D...
To assess the progress and limitation of chemotherapy in the treatment of small cell lung cancer in ...
The present study was conducted to determine whether it is justifiable to adapt treatment to age in ...
Wstęp. Rak płuc jest najczęściej diagnozowanym nowotworem płuc. Rocznie odnotowuje się 1,6 miliona z...
Elderly patients represent the majority of lung cancer cases, but they are often under-represented i...
BackgroundLung cancer has progressively become a disease of older people, with the median age at dia...
Background: Seventy-five percent of newly diagnosed patients with small-cell lung cancer (SCLC) are ...
Objectives: Over 20% of all newly diagnosed Dutch patients with small-cell lung cancer (SCLC) are ag...
Wstęp: Nowotwór złośliwy płuca jest drugim, co do częstości diagnozowanym w Polsce oraz główną przy...
Lung cancer is in Poland the most common malignancy. Non-small cell lung cancer (NSCLC) accounts for...
Rak płuca jest najczęściej występującym w Polsce i na świecie nowotworem złośliwym, niestety zbyt pó...
Lung cancer is the most common human malignancy. Treatment of this tumor is still unsatisfactory and...
Lung cancer is the most common cause of cancer-related death both in men and women in Poland and wor...
AbstractLung cancer is the most common cause of cancer death. With the aging of the population, more...
Malignant neoplasms are in Poland a major social problem not only in the older age groups, but they ...
There is a growing number of evidence that elderly cancer patients can benefit oncology treatment. D...
To assess the progress and limitation of chemotherapy in the treatment of small cell lung cancer in ...
The present study was conducted to determine whether it is justifiable to adapt treatment to age in ...
Wstęp. Rak płuc jest najczęściej diagnozowanym nowotworem płuc. Rocznie odnotowuje się 1,6 miliona z...
Elderly patients represent the majority of lung cancer cases, but they are often under-represented i...
BackgroundLung cancer has progressively become a disease of older people, with the median age at dia...
Background: Seventy-five percent of newly diagnosed patients with small-cell lung cancer (SCLC) are ...
Objectives: Over 20% of all newly diagnosed Dutch patients with small-cell lung cancer (SCLC) are ag...